from admin | Sep 26, 2022 | News
Browning JC et al. August 2022 - JAMA Dermatology DOI:10.1001/jamadermatol.2022.2721 From this double-blind case-control study, 891 participants with multiple molluscum contagiosum (3 to 70), aged more than six months...
from admin | Sep 26, 2022 | News
Treat JR. July 2022 - Medscape When adolescents present with acne that does not respond to isotretinoin, it is necessary to ensure that they take the drug along with fatty foods, which are known to increase its bioavailability. Thus he recommends...
from admin | Sep 26, 2022 | News
July 2022 The US Food and Drug Administration has approved topical ruxolitinib (Opzelura) for the treatment of nonsegmental vitiligo in patients 12 years of age and older. The Janus kinase 1/JAK2 inhibitor, formulated as a cream had been...
from admin | Sep 26, 2022 | News
June 2022 The Food and Drug Administration approved (on June 7, 2022) Dupilumab as an adjunctive maintenance treatment for children aged 6 months to 5 years with moderate to severe atopic dermatitis whose disease is not adequately...
from admin | Sep 26, 2022 | News
April 2022 A topical gel containing birch bark extract as an active ingredient--Filsuvez (Oleogel-S10)--has been recommended for approval for the treatment of skin wounds in patients with epidermolysis bullosa (EB) by the...
from admin | Sep 26, 2022 | News
March 2022 - Health News Christopher G. Bunick, associate professor of dermatology at Yale University, New Haven, Conn. said at a session of the American Academy of Dermatology that according to a phase 2 study (called CONTROL) patients...
